Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis

References

• Chelliah J, Freemerman AJ, Wu-Pong S, Jarvis WD, Grant S. Potentiation of ara-C-induced apoptosis by the protein kinase C activator bryostatin 1 in human leukemia cells (HL-60) involves a process dependent upon c-Myc. Biochem Pharmacol 1997; 54: 563–573.
   PubMed Web of Science ®Google Scholar
• Qin L, Zhang X, Zhang L. Downregulation of BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal carcinoma cells. Biochem Biophys Res Commun 2008; 371: 531–535.
   PubMed Web of Science ®Google Scholar
• Martin-Aragon S, Mukherjee SK, Taylor BJ et al. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs. Anticancer Res 2000; 20: 139–150.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Srivastava DA. Developmental view of microRNA function. Trends Biochem Sci 2007; 32: 189–197.
   PubMed Web of Science ®Google Scholar
• Griffiths-Jones S, Grocock RJ, van Dongen S. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006; 34: 140–144.
   PubMed Web of Science ®Google Scholar
• Yu ZB, Jian ZF, Shen SH. Global analysis of microRNA targetgene expression reveals that miRNA targets are lower expressed in mature mouse and Drosophila tissues than in the embryos. Nucleic Acids Res 2007; 35: 152–164.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281–297.
   PubMed Web of Science ®Google Scholar
• Harfe BD. MicroRNAs in vertebrate development. Curr Opin Genet Dev 2005; 15: 410–415.
   PubMed Web of Science ®Google Scholar
• Blower PE, Chung JH, Verducci JS. MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 2008; 7: 1–9.
   PubMed Web of Science ®Google Scholar
• Zhu H, Wu H, Liu X, Evans BR, Medina DJ. Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 2008; 76: 582–588.
   PubMed Web of Science ®Google Scholar
• Xia L, Zhang D, Du R et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 2008; 123: 372–379.
   PubMed Web of Science ®Google Scholar
• Lu Z, Liu M, Stribinskis V. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 2008; 27: 4373–4379.
   PubMed Web of Science ®Google Scholar
• Manikandan J, Aarthi JJ, Kumar SD, Pushparaj PN. Oncomirs: the potential role of non-coding microRNAs in understanding cancer. Bioinformation 2008; 2: 330–334.
   PubMedGoogle Scholar
• Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302: 1–12.
   PubMed Web of Science ®Google Scholar
• Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006; 25: 6188–6196.
   PubMed Web of Science ®Google Scholar
• Si ML, Zhu S, Wu Z, Lu F, Mo YY. miR-21-mediated tumor growth. Oncogene 2007; 26: 2799–2803.
   PubMed Web of Science ®Google Scholar
• Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006,24: 4677–4684.
   PubMed Web of Science ®Google Scholar
• Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65: 6029–6033.
   PubMed Web of Science ®Google Scholar
• Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006; 130: 2113–2129.
   PubMed Web of Science ®Google Scholar
• Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259–269.
   PubMed Web of Science ®Google Scholar
• Asangani IA, Rasheed SA, Nikolova DA et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008; 27: 2128–2136.
   PubMed Web of Science ®Google Scholar
• Fraser M, Leung BM, Yan X, Dan HC, Cheng JQ, Tsang BK. p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells. Cancer Res 2003; 63: 7081–7088.
   PubMed Web of Science ®Google Scholar
• Oltvai ZN, Milliman CL, Korsmeyer Si. Bc1-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 1993; 74: 609–619.
   PubMed Web of Science ®Google Scholar
• Amundson SA, Myers TG, Scudiero DS, Kitada Si, Reed JC, Fornace AJ. An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res 2000; 60: 6101–6110.
   PubMed Web of Science ®Google Scholar
• Reed JC. Apoptosis-targeted therapies for cancer. Cancer Cell 2003; 3: 17–22.
   PubMed Web of Science ®Google Scholar
• Bettaieb A, Dubrez-Daloz L, Launay S et al. Bc1-2 proteins: targets and tools for chemosensitisation of tumor cells. Curr Med Chem Anticancer Agents 2003; 3, 307–318.
   PubMedGoogle Scholar
• Park WH, Cho HY, Jung CW et al. Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis. Biochem Biophys Res Commun 2003; 300: 230–235.
   PubMed Web of Science ®Google Scholar
• Esau CC. Inhibition of microRNA with antisense oligonucleotides.Methods 2008; 44: 55–60.
   PubMed Web of Science ®Google Scholar
• Davis S, Lollo B, Freier S. Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res 2006; 34: 2294–2304.
   PubMed Web of Science ®Google Scholar
• Cheng AM, Byrom MW, Shelton J. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005; 33: 1290–1297.
   PubMed Web of Science ®Google Scholar
• Kriitzfeldt J, Rajewsky N, Braich R et al. Silencing of microRNAsin vivo with `antagomirs'. Nature 2005; 438: 685–689.
   PubMed Web of Science ®Google Scholar
• Weiler J, Hunziker J, Hall J. Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Ther 2005; 13: 496–502.
   Web of Science ®Google Scholar